HIV pre-exposure prophylaxis (PrEP)

PrEP is a highly effective strategy that involves an HIV-negative person taking HIV medications on an ongoing basis to reduce the risk of HIV infection. When PrEP is taken as prescribed, HIV transmission is very rare.

Resources

Filter By

Filter By

Research summary

Best practices of same-day HIV pre-exposure prophylaxis (PrEP) initiation

Research summary

CATIE News 03092021

Australian researchers study syphilis in men who use HIV pre-exposure prophylaxis (PrEP)

Research summary

CATIE News 03042021

Study underscores need for HPV screening and vaccination in gay and bisexual PrEP users

Guideline or manual

Alberta HIV pre-exposure prophylaxis (PrEP) guidelines

Take PrEP on-demand

Research summary

microscope

Screening alcohol and substance use may ultimately help improve PrEP adherence

Research summary

Injectable cabotegravir highly successful at preventing HIV infection in women

Guideline or manual

Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia

Research summary

Long-acting injectable drug prevents HIV

Research summary

Same-day HIV Pre-Exposure Prophylaxis in an urban sexually transmitted infection clinic

Research summary

Pharmacist-Led, Same-Day, PrEP Program

Guideline or manual

Helping people access pre-exposure prophylaxis: A frontline provider manual on PrEP research, care and navigation